Global Injectable Anti-Wrinkle Market

Injectable Anti-Wrinkle Comprehensive Study by Type (Muscle Relaxants (Botox Injections, Others), Synthetic Wrinkle Fillers (Sculptra, Radiesse, Silicone), Autologous Wrinkle Fillers, Muscle Relaxants, Hyaluronic Acid Wrinkle Filler (Belotero Balance, Perlane, Restylane, Juvederm, Others), Collagen Wrinkle Fillers (Cosmoderm, Fibrel, Artefill, Evolence, Others)), Skin Condition (Forehead Lines, Crow’s Feet, Upper Lip Lines, Sagging Eyebrows, Hyperhidrosis, Frown Lines, Bunny Lines, Dimpled Chin) Players and Region - Global Market Outlook to 2030

Injectable Anti-Wrinkle Market by XX Submarkets | Forecast Years 2024-2030 | CAGR: 14.9%  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
About Injectable Anti-Wrinkle
The growing demand for face treatment will help to boost the demand of global Injectable Anti-Wrinkle market in the forecasted period. Injectable Anti-Wrinkle is a type of treatment which is used to reduce the wrinkles and the skin lines. in this treatment, drugs are injected into the treatment area. It can provide facility such as the skin tight and can fill the sagging skin, frown lines reduction, and lines that are present under the eyes. The anti-wrinkle injection is available in two types the first one in which dermal fillers are used to fill up the wrinkles the next in which botulinum toxin is used for the blockage of the nerve impulse that causes contraction. Another factor is that the baby boomer population is now moving towards their age of retirement and thus they are the major group of the population that is spending in the treatment.

AttributesDetails
Study Period2018-2030
Base Year2023
High Growth MarketAsia Pacific
UnitValue (USD Million)
CAGR14.9%


The companies in these industries are seeking ways to reduce costs, improve product quality and production efficiency. The focus is on improved productivity and reduced production cost structure. Smart production technology has provided with ample technological solutions for small and medium-sized companies and its users with connected supply chains. Analyst at AMA Research estimates that Global Players will contribute the maximum growth to Global Injectable Anti-Wrinkle market throughout the forecasted period. Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.

Maryland Dermatology Laser (United States), Skin & Vein Institute (United States), Galderma Laboratories (United States), Merz North America (United States), Laser & Skin (Ireland) and Allergan (Ireland) are some of the key players that are part of study coverage.

Segmentation Overview
AMA Research has segmented the market of Global Injectable Anti-Wrinkle market by Type (Muscle Relaxants [Botox Injections, Others], Synthetic Wrinkle Fillers [Sculptra, Radiesse, Silicone], Autologous Wrinkle Fillers, Muscle Relaxants, Hyaluronic Acid Wrinkle Filler [Belotero Balance, Perlane, Restylane, Juvederm, Others] and Collagen Wrinkle Fillers [Cosmoderm, Fibrel, Artefill, Evolence, Others]) and Region.



On the basis of geography, the market of Injectable Anti-Wrinkle has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). North America region held largest market share in the year 2023. Europe, on the other hand, stood as the second largest market due to the presence of key companies in the region and high technological advancement. If we see Market by Skin Condition, the sub-segment i.e. Forehead Lines will boost the Injectable Anti-Wrinkle market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Influencing Trend:
Increase in the Awareness, The Growing Concerns About The Physical Beauty among The People and The Rise in the Number of the Geriatric Population

Market Growth Drivers:
The Rise in demand from Consumers due to Less Time Consuming, The Rise in Obesity and High Adoption Due to Non-Invasive Procedure

Challenges:
Stringent Regulatory Concerns

Restraints:
Safety and Efficacy Concerns and High Treatment Cost

Opportunities:
Availability of the Technologically Advanced Procedure and Growing Demand From Emerging Countries

Market Leaders and their expansionary development strategies
In June 2023, Allergan Aesthetics, an AbbVie company (NYSE: ABBV) today announced the 20 incredible women entrepreneurs who will receive funding and mentorship through the BOTOX Cosmetic and IFundWomen grant program. More than 6,500 women submitted applications and each one was carefully reviewed by a panel to select the winners. While the number of women-owned businesses in the country continues to grow, and is now estimated at 42 percent of all businesses
In February 2024, Merz Aesthetics announced today the approval for Radiesse® to treat the décolleté area. Radiesse is a regenerative biostimulator1 capable of regenerating multiple components of the skin tissue, resulting in healthier-looking skin,1,4,5 and is now approved for use in the décolletage, adding to the product’s versatility.


Key Target Audience
Injectable Anti-Wrinkle Treatment Providers, Regulatory Bodies, Government Research Organizations, Private Research Organizations and Others

About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have a better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with the purpose to understand the companies positioning regarding the market value, volume, and their market share for regional as well as global.

Further to bring relevance specific to any niche market we set and apply a number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders, etc., and work towards appointment generation.

The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, the analyst team keeps preparing a set of questionnaires, and after getting the appointee list; the target audience is then tapped and segregated with various mediums and channels that are feasible for making connections that including email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey, etc.

Report Objectives / Segmentation Covered

By Type
  • Muscle Relaxants [Botox Injections, Others]
  • Synthetic Wrinkle Fillers [Sculptra, Radiesse, Silicone]
  • Autologous Wrinkle Fillers
  • Muscle Relaxants
  • Hyaluronic Acid Wrinkle Filler [Belotero Balance, Perlane, Restylane, Juvederm, Others]
  • Collagen Wrinkle Fillers [Cosmoderm, Fibrel, Artefill, Evolence, Others]
By Skin Condition
  • Forehead Lines
  • Crow’s Feet
  • Upper Lip Lines
  • Sagging Eyebrows
  • Hyperhidrosis
  • Frown Lines
  • Bunny Lines
  • Dimpled Chin

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. The Rise in demand from Consumers due to Less Time Consuming
      • 3.2.2. The Rise in Obesity
      • 3.2.3. High Adoption Due to Non-Invasive Procedure
    • 3.3. Market Challenges
      • 3.3.1. Stringent Regulatory Concerns
    • 3.4. Market Trends
      • 3.4.1. Increase in the Awareness
      • 3.4.2. The Growing Concerns About The Physical Beauty among The People
      • 3.4.3. The Rise in the Number of the Geriatric Population
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Injectable Anti-Wrinkle, by Type, Skin Condition and Region (value) (2018-2023)
    • 5.1. Introduction
    • 5.2. Global Injectable Anti-Wrinkle (Value)
      • 5.2.1. Global Injectable Anti-Wrinkle by: Type (Value)
        • 5.2.1.1. Muscle Relaxants [Botox Injections, Others]
        • 5.2.1.2. Synthetic Wrinkle Fillers [Sculptra, Radiesse, Silicone]
        • 5.2.1.3. Autologous Wrinkle Fillers
        • 5.2.1.4. Muscle Relaxants
        • 5.2.1.5. Hyaluronic Acid Wrinkle Filler [Belotero Balance, Perlane, Restylane, Juvederm, Others]
        • 5.2.1.6. Collagen Wrinkle Fillers [Cosmoderm, Fibrel, Artefill, Evolence, Others]
      • 5.2.2. Global Injectable Anti-Wrinkle by: Skin Condition (Value)
        • 5.2.2.1. Forehead Lines
        • 5.2.2.2. Crow’s Feet
        • 5.2.2.3. Upper Lip Lines
        • 5.2.2.4. Sagging Eyebrows
        • 5.2.2.5. Hyperhidrosis
        • 5.2.2.6. Frown Lines
        • 5.2.2.7. Bunny Lines
        • 5.2.2.8. Dimpled Chin
      • 5.2.3. Global Injectable Anti-Wrinkle Region
        • 5.2.3.1. South America
          • 5.2.3.1.1. Brazil
          • 5.2.3.1.2. Argentina
          • 5.2.3.1.3. Rest of South America
        • 5.2.3.2. Asia Pacific
          • 5.2.3.2.1. China
          • 5.2.3.2.2. Japan
          • 5.2.3.2.3. India
          • 5.2.3.2.4. South Korea
          • 5.2.3.2.5. Taiwan
          • 5.2.3.2.6. Australia
          • 5.2.3.2.7. Rest of Asia-Pacific
        • 5.2.3.3. Europe
          • 5.2.3.3.1. Germany
          • 5.2.3.3.2. France
          • 5.2.3.3.3. Italy
          • 5.2.3.3.4. United Kingdom
          • 5.2.3.3.5. Netherlands
          • 5.2.3.3.6. Rest of Europe
        • 5.2.3.4. MEA
          • 5.2.3.4.1. Middle East
          • 5.2.3.4.2. Africa
        • 5.2.3.5. North America
          • 5.2.3.5.1. United States
          • 5.2.3.5.2. Canada
          • 5.2.3.5.3. Mexico
  • 6. Injectable Anti-Wrinkle: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
    • 6.2. Peer Group Analysis (2023)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Maryland Dermatology Laser (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Skin & Vein Institute (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Galderma Laboratories (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Merz North America (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Laser & Skin (Ireland)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Allergan (Ireland)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
  • 7. Global Injectable Anti-Wrinkle Sale, by Type, Skin Condition and Region (value) (2025-2030)
    • 7.1. Introduction
    • 7.2. Global Injectable Anti-Wrinkle (Value)
      • 7.2.1. Global Injectable Anti-Wrinkle by: Type (Value)
        • 7.2.1.1. Muscle Relaxants [Botox Injections, Others]
        • 7.2.1.2. Synthetic Wrinkle Fillers [Sculptra, Radiesse, Silicone]
        • 7.2.1.3. Autologous Wrinkle Fillers
        • 7.2.1.4. Muscle Relaxants
        • 7.2.1.5. Hyaluronic Acid Wrinkle Filler [Belotero Balance, Perlane, Restylane, Juvederm, Others]
        • 7.2.1.6. Collagen Wrinkle Fillers [Cosmoderm, Fibrel, Artefill, Evolence, Others]
      • 7.2.2. Global Injectable Anti-Wrinkle by: Skin Condition (Value)
        • 7.2.2.1. Forehead Lines
        • 7.2.2.2. Crow’s Feet
        • 7.2.2.3. Upper Lip Lines
        • 7.2.2.4. Sagging Eyebrows
        • 7.2.2.5. Hyperhidrosis
        • 7.2.2.6. Frown Lines
        • 7.2.2.7. Bunny Lines
        • 7.2.2.8. Dimpled Chin
      • 7.2.3. Global Injectable Anti-Wrinkle Region
        • 7.2.3.1. South America
          • 7.2.3.1.1. Brazil
          • 7.2.3.1.2. Argentina
          • 7.2.3.1.3. Rest of South America
        • 7.2.3.2. Asia Pacific
          • 7.2.3.2.1. China
          • 7.2.3.2.2. Japan
          • 7.2.3.2.3. India
          • 7.2.3.2.4. South Korea
          • 7.2.3.2.5. Taiwan
          • 7.2.3.2.6. Australia
          • 7.2.3.2.7. Rest of Asia-Pacific
        • 7.2.3.3. Europe
          • 7.2.3.3.1. Germany
          • 7.2.3.3.2. France
          • 7.2.3.3.3. Italy
          • 7.2.3.3.4. United Kingdom
          • 7.2.3.3.5. Netherlands
          • 7.2.3.3.6. Rest of Europe
        • 7.2.3.4. MEA
          • 7.2.3.4.1. Middle East
          • 7.2.3.4.2. Africa
        • 7.2.3.5. North America
          • 7.2.3.5.1. United States
          • 7.2.3.5.2. Canada
          • 7.2.3.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Injectable Anti-Wrinkle: by Type(USD Million)
  • Table 2. Injectable Anti-Wrinkle Muscle Relaxants [Botox Injections, Others] , by Region USD Million (2018-2023)
  • Table 3. Injectable Anti-Wrinkle Synthetic Wrinkle Fillers [Sculptra, Radiesse, Silicone] , by Region USD Million (2018-2023)
  • Table 4. Injectable Anti-Wrinkle Autologous Wrinkle Fillers , by Region USD Million (2018-2023)
  • Table 5. Injectable Anti-Wrinkle Muscle Relaxants , by Region USD Million (2018-2023)
  • Table 6. Injectable Anti-Wrinkle Hyaluronic Acid Wrinkle Filler [Belotero Balance, Perlane, Restylane, Juvederm, Others] , by Region USD Million (2018-2023)
  • Table 7. Injectable Anti-Wrinkle Collagen Wrinkle Fillers [Cosmoderm, Fibrel, Artefill, Evolence, Others] , by Region USD Million (2018-2023)
  • Table 8. Injectable Anti-Wrinkle: by Skin Condition(USD Million)
  • Table 9. Injectable Anti-Wrinkle Forehead Lines , by Region USD Million (2018-2023)
  • Table 10. Injectable Anti-Wrinkle Crow’s Feet , by Region USD Million (2018-2023)
  • Table 11. Injectable Anti-Wrinkle Upper Lip Lines , by Region USD Million (2018-2023)
  • Table 12. Injectable Anti-Wrinkle Sagging Eyebrows , by Region USD Million (2018-2023)
  • Table 13. Injectable Anti-Wrinkle Hyperhidrosis , by Region USD Million (2018-2023)
  • Table 14. Injectable Anti-Wrinkle Frown Lines , by Region USD Million (2018-2023)
  • Table 15. Injectable Anti-Wrinkle Bunny Lines , by Region USD Million (2018-2023)
  • Table 16. Injectable Anti-Wrinkle Dimpled Chin , by Region USD Million (2018-2023)
  • Table 17. South America Injectable Anti-Wrinkle, by Country USD Million (2018-2023)
  • Table 18. South America Injectable Anti-Wrinkle, by Type USD Million (2018-2023)
  • Table 19. South America Injectable Anti-Wrinkle, by Skin Condition USD Million (2018-2023)
  • Table 20. Brazil Injectable Anti-Wrinkle, by Type USD Million (2018-2023)
  • Table 21. Brazil Injectable Anti-Wrinkle, by Skin Condition USD Million (2018-2023)
  • Table 22. Argentina Injectable Anti-Wrinkle, by Type USD Million (2018-2023)
  • Table 23. Argentina Injectable Anti-Wrinkle, by Skin Condition USD Million (2018-2023)
  • Table 24. Rest of South America Injectable Anti-Wrinkle, by Type USD Million (2018-2023)
  • Table 25. Rest of South America Injectable Anti-Wrinkle, by Skin Condition USD Million (2018-2023)
  • Table 26. Asia Pacific Injectable Anti-Wrinkle, by Country USD Million (2018-2023)
  • Table 27. Asia Pacific Injectable Anti-Wrinkle, by Type USD Million (2018-2023)
  • Table 28. Asia Pacific Injectable Anti-Wrinkle, by Skin Condition USD Million (2018-2023)
  • Table 29. China Injectable Anti-Wrinkle, by Type USD Million (2018-2023)
  • Table 30. China Injectable Anti-Wrinkle, by Skin Condition USD Million (2018-2023)
  • Table 31. Japan Injectable Anti-Wrinkle, by Type USD Million (2018-2023)
  • Table 32. Japan Injectable Anti-Wrinkle, by Skin Condition USD Million (2018-2023)
  • Table 33. India Injectable Anti-Wrinkle, by Type USD Million (2018-2023)
  • Table 34. India Injectable Anti-Wrinkle, by Skin Condition USD Million (2018-2023)
  • Table 35. South Korea Injectable Anti-Wrinkle, by Type USD Million (2018-2023)
  • Table 36. South Korea Injectable Anti-Wrinkle, by Skin Condition USD Million (2018-2023)
  • Table 37. Taiwan Injectable Anti-Wrinkle, by Type USD Million (2018-2023)
  • Table 38. Taiwan Injectable Anti-Wrinkle, by Skin Condition USD Million (2018-2023)
  • Table 39. Australia Injectable Anti-Wrinkle, by Type USD Million (2018-2023)
  • Table 40. Australia Injectable Anti-Wrinkle, by Skin Condition USD Million (2018-2023)
  • Table 41. Rest of Asia-Pacific Injectable Anti-Wrinkle, by Type USD Million (2018-2023)
  • Table 42. Rest of Asia-Pacific Injectable Anti-Wrinkle, by Skin Condition USD Million (2018-2023)
  • Table 43. Europe Injectable Anti-Wrinkle, by Country USD Million (2018-2023)
  • Table 44. Europe Injectable Anti-Wrinkle, by Type USD Million (2018-2023)
  • Table 45. Europe Injectable Anti-Wrinkle, by Skin Condition USD Million (2018-2023)
  • Table 46. Germany Injectable Anti-Wrinkle, by Type USD Million (2018-2023)
  • Table 47. Germany Injectable Anti-Wrinkle, by Skin Condition USD Million (2018-2023)
  • Table 48. France Injectable Anti-Wrinkle, by Type USD Million (2018-2023)
  • Table 49. France Injectable Anti-Wrinkle, by Skin Condition USD Million (2018-2023)
  • Table 50. Italy Injectable Anti-Wrinkle, by Type USD Million (2018-2023)
  • Table 51. Italy Injectable Anti-Wrinkle, by Skin Condition USD Million (2018-2023)
  • Table 52. United Kingdom Injectable Anti-Wrinkle, by Type USD Million (2018-2023)
  • Table 53. United Kingdom Injectable Anti-Wrinkle, by Skin Condition USD Million (2018-2023)
  • Table 54. Netherlands Injectable Anti-Wrinkle, by Type USD Million (2018-2023)
  • Table 55. Netherlands Injectable Anti-Wrinkle, by Skin Condition USD Million (2018-2023)
  • Table 56. Rest of Europe Injectable Anti-Wrinkle, by Type USD Million (2018-2023)
  • Table 57. Rest of Europe Injectable Anti-Wrinkle, by Skin Condition USD Million (2018-2023)
  • Table 58. MEA Injectable Anti-Wrinkle, by Country USD Million (2018-2023)
  • Table 59. MEA Injectable Anti-Wrinkle, by Type USD Million (2018-2023)
  • Table 60. MEA Injectable Anti-Wrinkle, by Skin Condition USD Million (2018-2023)
  • Table 61. Middle East Injectable Anti-Wrinkle, by Type USD Million (2018-2023)
  • Table 62. Middle East Injectable Anti-Wrinkle, by Skin Condition USD Million (2018-2023)
  • Table 63. Africa Injectable Anti-Wrinkle, by Type USD Million (2018-2023)
  • Table 64. Africa Injectable Anti-Wrinkle, by Skin Condition USD Million (2018-2023)
  • Table 65. North America Injectable Anti-Wrinkle, by Country USD Million (2018-2023)
  • Table 66. North America Injectable Anti-Wrinkle, by Type USD Million (2018-2023)
  • Table 67. North America Injectable Anti-Wrinkle, by Skin Condition USD Million (2018-2023)
  • Table 68. United States Injectable Anti-Wrinkle, by Type USD Million (2018-2023)
  • Table 69. United States Injectable Anti-Wrinkle, by Skin Condition USD Million (2018-2023)
  • Table 70. Canada Injectable Anti-Wrinkle, by Type USD Million (2018-2023)
  • Table 71. Canada Injectable Anti-Wrinkle, by Skin Condition USD Million (2018-2023)
  • Table 72. Mexico Injectable Anti-Wrinkle, by Type USD Million (2018-2023)
  • Table 73. Mexico Injectable Anti-Wrinkle, by Skin Condition USD Million (2018-2023)
  • Table 74. Company Basic Information, Sales Area and Its Competitors
  • Table 75. Company Basic Information, Sales Area and Its Competitors
  • Table 76. Company Basic Information, Sales Area and Its Competitors
  • Table 77. Company Basic Information, Sales Area and Its Competitors
  • Table 78. Company Basic Information, Sales Area and Its Competitors
  • Table 79. Company Basic Information, Sales Area and Its Competitors
  • Table 80. Injectable Anti-Wrinkle: by Type(USD Million)
  • Table 81. Injectable Anti-Wrinkle Muscle Relaxants [Botox Injections, Others] , by Region USD Million (2025-2030)
  • Table 82. Injectable Anti-Wrinkle Synthetic Wrinkle Fillers [Sculptra, Radiesse, Silicone] , by Region USD Million (2025-2030)
  • Table 83. Injectable Anti-Wrinkle Autologous Wrinkle Fillers , by Region USD Million (2025-2030)
  • Table 84. Injectable Anti-Wrinkle Muscle Relaxants , by Region USD Million (2025-2030)
  • Table 85. Injectable Anti-Wrinkle Hyaluronic Acid Wrinkle Filler [Belotero Balance, Perlane, Restylane, Juvederm, Others] , by Region USD Million (2025-2030)
  • Table 86. Injectable Anti-Wrinkle Collagen Wrinkle Fillers [Cosmoderm, Fibrel, Artefill, Evolence, Others] , by Region USD Million (2025-2030)
  • Table 87. Injectable Anti-Wrinkle: by Skin Condition(USD Million)
  • Table 88. Injectable Anti-Wrinkle Forehead Lines , by Region USD Million (2025-2030)
  • Table 89. Injectable Anti-Wrinkle Crow’s Feet , by Region USD Million (2025-2030)
  • Table 90. Injectable Anti-Wrinkle Upper Lip Lines , by Region USD Million (2025-2030)
  • Table 91. Injectable Anti-Wrinkle Sagging Eyebrows , by Region USD Million (2025-2030)
  • Table 92. Injectable Anti-Wrinkle Hyperhidrosis , by Region USD Million (2025-2030)
  • Table 93. Injectable Anti-Wrinkle Frown Lines , by Region USD Million (2025-2030)
  • Table 94. Injectable Anti-Wrinkle Bunny Lines , by Region USD Million (2025-2030)
  • Table 95. Injectable Anti-Wrinkle Dimpled Chin , by Region USD Million (2025-2030)
  • Table 96. South America Injectable Anti-Wrinkle, by Country USD Million (2025-2030)
  • Table 97. South America Injectable Anti-Wrinkle, by Type USD Million (2025-2030)
  • Table 98. South America Injectable Anti-Wrinkle, by Skin Condition USD Million (2025-2030)
  • Table 99. Brazil Injectable Anti-Wrinkle, by Type USD Million (2025-2030)
  • Table 100. Brazil Injectable Anti-Wrinkle, by Skin Condition USD Million (2025-2030)
  • Table 101. Argentina Injectable Anti-Wrinkle, by Type USD Million (2025-2030)
  • Table 102. Argentina Injectable Anti-Wrinkle, by Skin Condition USD Million (2025-2030)
  • Table 103. Rest of South America Injectable Anti-Wrinkle, by Type USD Million (2025-2030)
  • Table 104. Rest of South America Injectable Anti-Wrinkle, by Skin Condition USD Million (2025-2030)
  • Table 105. Asia Pacific Injectable Anti-Wrinkle, by Country USD Million (2025-2030)
  • Table 106. Asia Pacific Injectable Anti-Wrinkle, by Type USD Million (2025-2030)
  • Table 107. Asia Pacific Injectable Anti-Wrinkle, by Skin Condition USD Million (2025-2030)
  • Table 108. China Injectable Anti-Wrinkle, by Type USD Million (2025-2030)
  • Table 109. China Injectable Anti-Wrinkle, by Skin Condition USD Million (2025-2030)
  • Table 110. Japan Injectable Anti-Wrinkle, by Type USD Million (2025-2030)
  • Table 111. Japan Injectable Anti-Wrinkle, by Skin Condition USD Million (2025-2030)
  • Table 112. India Injectable Anti-Wrinkle, by Type USD Million (2025-2030)
  • Table 113. India Injectable Anti-Wrinkle, by Skin Condition USD Million (2025-2030)
  • Table 114. South Korea Injectable Anti-Wrinkle, by Type USD Million (2025-2030)
  • Table 115. South Korea Injectable Anti-Wrinkle, by Skin Condition USD Million (2025-2030)
  • Table 116. Taiwan Injectable Anti-Wrinkle, by Type USD Million (2025-2030)
  • Table 117. Taiwan Injectable Anti-Wrinkle, by Skin Condition USD Million (2025-2030)
  • Table 118. Australia Injectable Anti-Wrinkle, by Type USD Million (2025-2030)
  • Table 119. Australia Injectable Anti-Wrinkle, by Skin Condition USD Million (2025-2030)
  • Table 120. Rest of Asia-Pacific Injectable Anti-Wrinkle, by Type USD Million (2025-2030)
  • Table 121. Rest of Asia-Pacific Injectable Anti-Wrinkle, by Skin Condition USD Million (2025-2030)
  • Table 122. Europe Injectable Anti-Wrinkle, by Country USD Million (2025-2030)
  • Table 123. Europe Injectable Anti-Wrinkle, by Type USD Million (2025-2030)
  • Table 124. Europe Injectable Anti-Wrinkle, by Skin Condition USD Million (2025-2030)
  • Table 125. Germany Injectable Anti-Wrinkle, by Type USD Million (2025-2030)
  • Table 126. Germany Injectable Anti-Wrinkle, by Skin Condition USD Million (2025-2030)
  • Table 127. France Injectable Anti-Wrinkle, by Type USD Million (2025-2030)
  • Table 128. France Injectable Anti-Wrinkle, by Skin Condition USD Million (2025-2030)
  • Table 129. Italy Injectable Anti-Wrinkle, by Type USD Million (2025-2030)
  • Table 130. Italy Injectable Anti-Wrinkle, by Skin Condition USD Million (2025-2030)
  • Table 131. United Kingdom Injectable Anti-Wrinkle, by Type USD Million (2025-2030)
  • Table 132. United Kingdom Injectable Anti-Wrinkle, by Skin Condition USD Million (2025-2030)
  • Table 133. Netherlands Injectable Anti-Wrinkle, by Type USD Million (2025-2030)
  • Table 134. Netherlands Injectable Anti-Wrinkle, by Skin Condition USD Million (2025-2030)
  • Table 135. Rest of Europe Injectable Anti-Wrinkle, by Type USD Million (2025-2030)
  • Table 136. Rest of Europe Injectable Anti-Wrinkle, by Skin Condition USD Million (2025-2030)
  • Table 137. MEA Injectable Anti-Wrinkle, by Country USD Million (2025-2030)
  • Table 138. MEA Injectable Anti-Wrinkle, by Type USD Million (2025-2030)
  • Table 139. MEA Injectable Anti-Wrinkle, by Skin Condition USD Million (2025-2030)
  • Table 140. Middle East Injectable Anti-Wrinkle, by Type USD Million (2025-2030)
  • Table 141. Middle East Injectable Anti-Wrinkle, by Skin Condition USD Million (2025-2030)
  • Table 142. Africa Injectable Anti-Wrinkle, by Type USD Million (2025-2030)
  • Table 143. Africa Injectable Anti-Wrinkle, by Skin Condition USD Million (2025-2030)
  • Table 144. North America Injectable Anti-Wrinkle, by Country USD Million (2025-2030)
  • Table 145. North America Injectable Anti-Wrinkle, by Type USD Million (2025-2030)
  • Table 146. North America Injectable Anti-Wrinkle, by Skin Condition USD Million (2025-2030)
  • Table 147. United States Injectable Anti-Wrinkle, by Type USD Million (2025-2030)
  • Table 148. United States Injectable Anti-Wrinkle, by Skin Condition USD Million (2025-2030)
  • Table 149. Canada Injectable Anti-Wrinkle, by Type USD Million (2025-2030)
  • Table 150. Canada Injectable Anti-Wrinkle, by Skin Condition USD Million (2025-2030)
  • Table 151. Mexico Injectable Anti-Wrinkle, by Type USD Million (2025-2030)
  • Table 152. Mexico Injectable Anti-Wrinkle, by Skin Condition USD Million (2025-2030)
  • Table 153. Research Programs/Design for This Report
  • Table 154. Key Data Information from Secondary Sources
  • Table 155. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Injectable Anti-Wrinkle: by Type USD Million (2018-2023)
  • Figure 5. Global Injectable Anti-Wrinkle: by Skin Condition USD Million (2018-2023)
  • Figure 6. South America Injectable Anti-Wrinkle Share (%), by Country
  • Figure 7. Asia Pacific Injectable Anti-Wrinkle Share (%), by Country
  • Figure 8. Europe Injectable Anti-Wrinkle Share (%), by Country
  • Figure 9. MEA Injectable Anti-Wrinkle Share (%), by Country
  • Figure 10. North America Injectable Anti-Wrinkle Share (%), by Country
  • Figure 11. Global Injectable Anti-Wrinkle share by Players 2023 (%)
  • Figure 12. Global Injectable Anti-Wrinkle share by Players (Top 3) 2023(%)
  • Figure 13. BCG Matrix for key Companies
  • Figure 14. Maryland Dermatology Laser (United States) Revenue, Net Income and Gross profit
  • Figure 15. Maryland Dermatology Laser (United States) Revenue: by Geography 2023
  • Figure 16. Skin & Vein Institute (United States) Revenue, Net Income and Gross profit
  • Figure 17. Skin & Vein Institute (United States) Revenue: by Geography 2023
  • Figure 18. Galderma Laboratories (United States) Revenue, Net Income and Gross profit
  • Figure 19. Galderma Laboratories (United States) Revenue: by Geography 2023
  • Figure 20. Merz North America (United States) Revenue, Net Income and Gross profit
  • Figure 21. Merz North America (United States) Revenue: by Geography 2023
  • Figure 22. Laser & Skin (Ireland) Revenue, Net Income and Gross profit
  • Figure 23. Laser & Skin (Ireland) Revenue: by Geography 2023
  • Figure 24. Allergan (Ireland) Revenue, Net Income and Gross profit
  • Figure 25. Allergan (Ireland) Revenue: by Geography 2023
  • Figure 26. Global Injectable Anti-Wrinkle: by Type USD Million (2025-2030)
  • Figure 27. Global Injectable Anti-Wrinkle: by Skin Condition USD Million (2025-2030)
  • Figure 28. South America Injectable Anti-Wrinkle Share (%), by Country
  • Figure 29. Asia Pacific Injectable Anti-Wrinkle Share (%), by Country
  • Figure 30. Europe Injectable Anti-Wrinkle Share (%), by Country
  • Figure 31. MEA Injectable Anti-Wrinkle Share (%), by Country
  • Figure 32. North America Injectable Anti-Wrinkle Share (%), by Country
List of companies from research coverage that are profiled in the study
  • Maryland Dermatology Laser (United States)
  • Skin & Vein Institute (United States)
  • Galderma Laboratories (United States)
  • Merz North America (United States)
  • Laser & Skin (Ireland)
  • Allergan (Ireland)
Select User Access Type

Key Highlights of Report


Apr 2024 214 Pages 56 Tables Base Year: 2023 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Injectable Anti-Wrinkle Market Quantitative research analysis
Global Injectable Anti-Wrinkle Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The standard version of the report profiles players such as Maryland Dermatology Laser (United States), Skin & Vein Institute (United States), Galderma Laboratories (United States), Merz North America (United States), Laser & Skin (Ireland) and Allergan (Ireland) etc.
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.
"Increase in the Awareness " is seen as one of major influencing trends for Injectable Anti-Wrinkle Market during projected period 2023-2030.
The Injectable Anti-Wrinkle market study includes a random mix of players, including both market leaders and some top growing emerging players. Connect with our sales executive to get a complete company list in our research coverage.

Know More About Global Injectable Anti-Wrinkle Market Report?

Have a Query? Click Here

Other Related Reports

Unna Boot Comprehensive Study by Application (Venous Leg Ulcers, Lymphedema, Eczema), Raw Material (Zinc Oxide, Zinc, Calamine), Distribution Channel (Offline Retail, Online Retail) Players and Regi...
$ 3500
RNA Based Therapeutics Comprehensive Study by Application (Cardiovascular, Kidney Diseases, Oncology, Infectious Diseases, Metabolic Disorders, Others), Technology (Inhibition, Microarrays, Labeling,...
$ 3650
Cancer Biological Therapy Comprehensive Study by Type (Monoclonal Antibodies, Vaccines, Cancer Growth Blockers, Blood Cell Growth Factors), Application (Hospitals, Diagnostic Laboratories, Research &...
$ 3650
Ascites Comprehensive Study by Type (Exudate Ascites, Transudative Ascites), Application (Hospitals, Clinics, Ambulatory Surgical Centers, Diagnostics Centers, Others), Diagnosis (Angiography, Ultras...
$ 3650
Acute Intermittent Porphyria Comprehensive Study by Treatment (Gonadotropin-Releasing Hormone Analogues, Prophylactic Hematin Infusions, Others), Diagnosis (Blood Test, Urine Test, DNA Test, Serum Te...
$ 3450
Neurodegenerative Diseases Comprehensive Study by Application (Alzheimer's Disease, Huntington Disease, Parkinson's Disease, Amyotrophic Lateral Sclerosis), Drug Type (N-methyl-D-aspartate Receptor, ...
$ 3450